Mirae Asset Global ETFs Holdings
HBIO icon

Mirae Asset Global ETFs Holdings’s Harvard Bioscience HBIO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,532
Closed -$14.3K – 3096
2025
Q1 		$14.3K Buy
2,532
+101
+4% +$1.29K ﹤0.01% 3007
2024
Q4 		$51.3K Buy
2,431
+99
+4% +$2.27K ﹤0.01% 2899
2024
Q3 		$62.7K Buy
2,332
+217
+10% +$6.39K ﹤0.01% 2871
2024
Q2 		$60.3K Buy
+2,115
New +$74.2K ﹤0.01% 2740

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's HBIO Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Harvard Bioscience (HBIO) in Q2 2025, closing a stake of 2,532 shares — an estimated $14.3K sold.

Mirae Asset Global ETFs Holdings first reported a position in HBIO in Q2 2024 and held it in 4 quarters. The position peaked at $62.7K in Q3 2024. 68 funds tracked by Wall St. Rank hold HBIO as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Harvard Bioscience position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 2,532 Harvard Bioscience shares in Q2 2025, an estimated $14.3K.
  • Mirae Asset Global ETFs Holdings first reported a position in Harvard Bioscience in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Harvard Bioscience position peaked at $62.7K in Q3 2024.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.